These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20300976)

  • 1. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
    Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X; Zhang Y; Wang S; Shi W
    Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
    Yang X; Liu Y; Zong Z; Tian D
    Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z; Ren JH; Li ZY; Nong L; Wu G
    Oncol Rep; 2012 May; 27(5):1561-6. PubMed ID: 22344855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
    Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
    Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.
    Zhang X; Wu N
    Drug Des Devel Ther; 2018; 12():373-381. PubMed ID: 29503530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
    Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
    Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G
    Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
    Guerra FS; Oliveira RG; Fraga CAM; Mermelstein CDS; Fernandes PD
    Sci Rep; 2017 Oct; 7(1):13723. PubMed ID: 29057980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
    Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
    Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
    Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H; Shimizu K
    Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
    Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
    Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.